High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study.
Year: 2009
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Paul G Richardson, Sagar Lonial, Andrzej J Jakubowiak, Sundar Jagannath, Noopur S Raje, David E Avigan, Irene Ghobrial, Robert L Schlossman, Amitabha Mazumder, Nikhil C. Munshi, Jacob Laubach, David Vesole, Robin Joyce, Jacalyn Rosenblatt, Wanling Xie, Deborah Doss, Diane L. Warren, Kate Ittleman, Carolyn Revta, Dixil Francis, Charles Leister, Sarah Kaster, Carol Delaney, Marisa Lauria, Constantine S. Mitsiades, Teru Hideshima, Robert Knight, Dixie-Lee Esseltine, Edie Weller, Kenneth C. Anderson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2554032537